Schedule 13G ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Common Stock, $0.001 par value · CUSIP: 252828108

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Octagon Capital Advisors LP

    Shares: 2,416,667.00 · Class: 6.1%

  • Octagon Investments Master Fund LP

    Shares: 2,125,000.00 · Class: 5.3%

  • Octagon Private Opportunities Fund II LP

    Shares: 291,667.00 · Class: 0.7%

  • Ting Jia

    Shares: 2,416,667.00 · Class: 6.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-016717
Form type
SCHEDULE 13G/A
Filer
Dianthus Therapeutics, Inc. /DE/
CIK
CIK 1690585
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub